¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"variable substrate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • insulin receptor substrate-1
    Àν¶¸°¼ö¿ëü±âÁú-1
  • renin substrate
    ·¹´Ñ±âÁú
  • respiratory substrate
    È£Èí±âÁú
  • substrate
    ±âÁú
  • substrate mycelium
    ±âÁú±Õ»çü
  • confounding variable
    ±³¶õº¯¼ö
  • continuous variable
    ¿¬¼Óº¯¼ö
  • dependent variable
    Á¾¼Óº¯¼ö
  • discrete variable
    À̻꺯¼ö
  • independent variable
    µ¶¸³º¯¼ö
  • variable
    º¯¼ö
  • variable bandwidth technique
    ´Ùº¯Á֯ļöÆø±â¹ý
  • variable coupling
    °¡º¯½Ä¿¬°á
  • variable region
    °¡º¯ºÎÀ§
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variable region
    °¡º¯ºÎÀ§
  • variable
    º¯¼ö, º¯
  • substrate
    ±âÁú
  • renin substrate
    ·¹´Ñ±âÁú
  • respiratory substrate
    È£Èí±âÁú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • substrate-labeled fluorescence immunoassay
    ±âÁúÇ¥ÁöÇü±¤¸é¿ªºÐ¼®(¹ý)
  • substrate mycelium
    ±âÁú±Õ»çü
  • renin substrate
    ·¹´Ñ±âÁú
  • respiratory substrate
    È£Èí±âÁú
  • substrate
    ±âÁú
  • antecedent variable
    ¼±Çຯ¼ö
  • binary variable
    ÀÌ¿ø¼ºº¯¼ö
  • confounding variable
    ±³¶õº¯¼ö
  • contingency variable
    Áß°£º¯¼ö
  • continuous variable
    ¿¬¼Óº¯¼ö
  • variable condenser
    °¡º¯ÃàÀü±â
  • variable coupling
    °¡º¯½Ä¿¬°á
  • dependent variable
    Á¾¼Óº¯¼ö
  • discrete variable
    À̻꺯¼ö, ºÒ¿¬¼Óº¯¼ö
  • distorter variable
    ±³¶õº¯¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SLFIA => substrate-labeled fluorescence imunoassay
    ±âÁúÇ¥ÁöÇü±¤¸é¿ªÃøÁ¤(¹ý)
  • hippurate substrate
    ¸¶´¢»ê±âÁú
  • independent variable
    µ¶¸³º¯¼ö.
  • independent variable
    µ¶¸³ º¯ÀÎ
  • intensity variable
    °­µµº¯¼ö.
  • renin substrate
    ·¹´Ñ±âÁú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hippurate substrate
    ¸¶´¢»ê±âÁú
  • leading substrate
    ¼±µµ±âÁú.
  • mycelium, substrate
    ±âÁú±Õ»çü
  • renin substrate
    ·¹´Ñ±âÁú.
  • respiratory substrate
    È£Èí±âÁú(û¼ýåѨòõ), È£Èí¹°Áú(û¼ýåÚªòõ).
  • substrate
    ±âÁú
  • substrate level phosphorylation
    ±âÁú±Þ ÀλêÈ­.
  • substrate-labeled fluorescence immunoassay(sLFIA)
    ±âÁúÇ¥ÁöÇü±¤¸é¿ªÃøÁ¤(¹ý)
  • bacterium, Gram-variable
    ±×¶÷¿°»ö¼º °¡º¯±Õ
  • common variable
    °øÅ뺯¼ö
  • common variable immunodeficiency
    Common variable immunodeficiency
  • continuous variable
    ¿¬¼Óº¯·®(ÊÙËÒËâ), ¿¬¼Óº¯¼ö.
  • dependent variable
    Á¾¼Óº¯¼ö(ÊÙËÒËà).
  • discrete variable
    À̻꺯¼ö, ºÒ¿¬¼Óº¯¼ö(ÊÙËÒËà).
  • independent variable
    µ¶¸³ º¯ÀÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variable surface glycoprotein (VSG)
    º¯À̼ºÇ¥¸é´ç´Ü¹éÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variable substrate
    °¡º¯±âÁú(ʦܨÐñòõ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • random variable
    ¹«ÀÛÀ§ º¯¼ö(ÙííÂêÓܨâ¦)
  • variable
    º¯¼ö(ܨâ¦)
  • variable arm
    °¡º¯(ʦܨ) ÆÈ
  • variable genes
    °¡º¯ºÎÀ§(ʦܨݻêÈ) À¯ÀüÀÚ (ë¶îîí­)
  • variable region
    °¡º¯ºÎÀ§(ʦܨݻêÈ)
  • covalent enzyme-substrate complex
    È¿¼Ò±âÁú °øÀ¯°áÇÕü(ý£áÈÐñòõÍìêóÌ¿ùêô÷) (ÔÒ) enzymesubstrate compound
  • enzyme-substrate complex
    È¿¼Ò-±âÁú º¹ÇÕü (ý£áÈÐñòõÜÜùêô÷)
  • enzyme-substrate compound
    È¿¼Ò-±âÁú È­ÇÕ¹° (ý£áÈÐñòõûùùêÚª)
  • enzyme-substrate intermediate
    È¿¼Ò-±âÁú Áß°£Ã¼ (ý£áÈÐñòõñéÊàô÷)
  • inverse substrate
    ¿ª ±âÁú(æ½Ðñòõ)
  • leading substrate
    ¼±µµ±âÁú(à»ÓôѨòõ)
  • normalized substrate concentration
    ³ë¸£¸» ±âÁú³óµµ(ѨòõÒØÓø)
  • reduced substrate concentration
    ȯ»ê ±âÁú ³óµµ(üµß©Ñ¨òõÒØÓø)
  • relative substrate concentration
    »ó´ë ±âÁú³óµµ(ßÓÓßÐñòõÒØÓø)
  • renin substrate
    ·¹´Ñ ±âÁú(Ðñòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variable
    º¯¼ö, °¡º¯ÀÇ, º¯È­ÀÖ´Â
  • variable bandwidth technique
    ´Ùº¯Á֯ļöÆø±â¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DV dependent variable; diagnostic variable; difference in volume; digital vibration; dilute volume; dis...
VH variable domain of heavy chain; variable heavy chain
VL variable domain of the light chain; variable light chain
VNTR variable number of tandem repeats; variable copy number tandem repeats
ASP abnormal spinal posture; acute symmetric polyarthritis; African swine pox; aged substrate plasma; al...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CAS Crk-associated substrate
IRS Insulin Receptor Substrate
IRS-2 Insulin receptor substrate 2
MARCKS Myristolated Alanine-Rich C-Kinase Substrate
PRS Plasma Renin Substrate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • leading substrate
    ¼±µµ ±âÁú
  • neuroanatomic substrate
    ½Å°æ ÇØºÎÇÐÀû ±âÁú, ½Å°æ ÇØºÎÇÐÀû ¹°Áú
  • substrate level phosphorylation
    ±âÁú±Þ ÀλêÈ­
  • zymolite µ¿ÀǾî=substrate.

    zymologist

    È¿¼ÒÇÐÀÚ
  • action variable
    ÀÛ¿ë º¯¼ö
  • psychologic variable
    ½É¸®ÀûÀÎ º¯¼ö
  • variable
    º¯¼ö, °¡º¯ÀÇ, º¯È­°¡ ÀÖ´Â
    µÑ ÀÌ»óÀÇ º¯È­ÇÒ ¼ö ÀÖ´Â »óÅ·Π³ªÅ¸³½ »ç¹°À̳ª Çö»óÀÇ ¼Ó¼º, ¾î¶°ÇÑ ´ëÀÀ°ü°è·Î º¯È­ÇÏ´Â ¼ö.
  • variable condenser
    °¡º¯ ÃàÀü±â
  • variable factor
    °¡º¯ ÀÎÀÚ
  • variable of integration
    ÀûºÐ º¯¼ö
  • variable region
    °¡º¯ ºÎÀ§
  • variable strabismus
    °¡º¯ »ç½Ã
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
substrate <chemistry> A substance upon which an enzyme acts.
Origin: L. Stratum = layer
(18 Nov 1997)
substrate cycle <biochemistry> Any seqence of enzyme catalysed reactions in which the forward and reverse processes (catalysed by different enzymes) are consititutively active.
Frequently used to describe the cycle of phosphorylation and dephosphorylation of phosphatidyl inositol derivatives in cell membranes.
(05 Jan 1998)
substrate cycling A set of opposing, nonequilibrium reactions catalyzed by different enzymes which act simultaneously, with at least one of the reactions driven by ATP hydrolysis. The results of the cycle are that ATP energy is depleted, heat is produced and no net substrate-to-product conversion is achieved. Examples of substrate cycling are cycling of gluconeogenesis and glycolysis pathways and cycling of the triglycerides and fatty acid pathways. Rates of substrate cycling may be increased many-fold in association with hypermetabolic states resulting from severe burns, cold exposure, hyperthyroidism, or acute exercise.
(12 Dec 1998)
substrate inhibition Inhibition of an enzyme activity by a substrate of the reaction catalyzed by that enzyme; often, this type of inhibition occurs at elevated substrate levels in which the substrate is binding to a second, non-active site on the enzyme.
(05 Mar 2000)
substrate-level phosphorylation Synthesis of high-energy phosphate bonds through reaction of inorganic phosphate with an activated (usually) organic substrate.
(09 Oct 1997)
substrate specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
(12 Dec 1998)
suicide substrate A competitive inhibitor that is converted to an irreversible inhibitor at the active site of the enzyme.
Synonym: mechanism-based inhibitor.
(05 Mar 2000)
insulin receptor substrate-1 protein <chemical> Amino acid sequence given in first source; a 180 kD protein that contains multiple phosphorylated tyrosine residues after insulin stimulation; human and rat forms (hirs-1 and irs-1) are homologous
Synonym: insulin receptor substrate-1-like protein, irs-1 protein, irs-1 gene product, hirs-1 protein, hirs-1 gene product, insulin receptor substrate 1, insulin receptor substrate-1
(05 Dec 1998)
enzyme-substrate complex A noncovalent complex of two molecules; often referring to the enzyme-substrate complex in an enzyme-catalyzed reaction.
Compare: central complex, Michaelis complex.
Synonym: enzyme-substrate complex.
(05 Mar 2000)
variable One of a battery of antigenicdeterminants expressed by a microorganismto elude immune detection.
(09 Oct 1997)
variable antigen <immunology> Term usually applied to the surface antigens of those parasitic or pathogenic organisms that can alter their antigenic character to evade host immune responses. (See antigenic variation).
(18 Nov 1997)
variable deceleration Transient foetal bradycardia usually denoting compression of the umbilical cord which may occur at any time in relation to a uterine contraction.
(05 Mar 2000)
variable gene <molecular biology> Those regions in the amino acid sequence of both the heavy and the light chains of immunoglobulins where there is considerable sequence variability from one immunoglobulin to other of the same class, in contrast to constant sequence (C) regions. The V regions are associated with the antigen binding areas. They contain hypervariable regions of particularly high sequence diversity.
(18 Nov 1997)
variable region <molecular biology> Those regions in the amino acid sequence of both the heavy and the light chains of immunoglobulins where there is considerable sequence variability from one immunoglobulin to other of the same class, in contrast to constant sequence (C) regions. The V regions are associated with the antigen binding areas. They contain hypervariable regions of particularly high sequence diversity.
(18 Nov 1997)
variable surface glycoprotein <protein> One of a battery of antigenicdeterminants expressed by a microorganism to elude immune detection.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • substrate
    ±âÁú(È¿¼ÒÀÇ ÀÛ¿ëÀ¸·Î È­ÇйÝÀÀÀ» ÀÏÀ¸Å°´Â ¹°Áú);(¼¼±ÕÀÇ)¹è¾ç±â
  • variable
    º¯Çϱ⽬¿î,º¯¼öÀÇ
  • Cepheid (variable)
    ÄÉÆäÀÌµå º¯±¤¼º
  • dependent variable
    (¼ö)Á¾¼Ó º¯¼ö 9
  • independent variable
    (¼ö)µ¶¸³º¯¼ö
  • random variable
    È®·üº¯¼ö
  • variable
    º¯Çϱ⠽¬¿î;º¯(°æ)ÇÒ ¼ö ÀÖ´Â;¹øÀÌÇÏ´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á